In three Brazilian infants with microcephaly, the researchers from Stanford University in the US and colleagues observed retinal lesions, hemorrhaging and abnormal blood vessel development not noted before in relation to the virus.
Zika virus is now known to cause microcephaly, a birth defect marked by smaller head and brain size. In Brazil, the site of the most serious outbreak, nearly 1.5 million people reportedly have the virus.
Some 4,000 infants were recently born with microcephaly, researchers said. As a result, the World Health Organisation (WHO) declared a public health emergency in February this year, bringing added urgency to the need for more research.
These included ocular lesions, optic nerve abnormalities and chorioretinal atrophy, a withering of the retina and choroid, the latter of which provides oxygen and nutrients to the retina.
For this case study, researchers examined the eyes of three infant boys from Northern Brazil born in late 2015 with microcephaly.
All had mothers with suspected Zika virus infections during the first trimester of pregnancy.
Researchers identified several types of ocular issues not previously observed in relation to Zika virus, some of which could cause visual impairment if untreated.
In addition to these observations, the infants exhibited other ocular symptoms noted in the previous study.
All three babies in this case study showed signs of pigmentary maculopathy, lesions that appear as speckles of pigment on the macula. Four eyes had symptoms of chorioretinal atrophy marked by a darkly pigmented ring.
The findings add to a growing body of clinical information about how the Zika virus may affect children's eye development and vision.
The researchers noted that it remains unclear whether the viral infection itself causes eye abnormalities or if they are a consequence of Zika-induced microcephaly.
"The next step is to differentiate what findings are related to the Zika virus itself versus microcephaly caused by the virus in order to better understand which infants will need screening," Moshfeghi said.
The findings appear in the journal Ophthalmology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
